Variation in neurocognitive and psychological symptoms between children and adults treated with elexacaftor/tezacaftor/ivacaftor (ETI)

被引：0
|
作者：
Barker, Jessica [1 ]
Krishan, Smriti [1 ]
Thomsen, Amanda [1 ]
Owens, Louisa [1 ,2 ]
Prentice, Bernadette [1 ,2 ]
机构：
[1] Sydney Childrens Hosp, Sydney, NSW, Australia
[2] Univ New South Wales, Sydney, NSW, Australia
来源：
RESPIROLOGY | 2024年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
103
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [41] Elevation of regulatory T Cells in Adults with CF receiving Elexacaftor/Tezacaftor/Ivacaftor Therapy
    Westhoelter, D.
    Ubner, H.
    Raspe, J.
    Schmitz, M.
    Ngoc, Tran L.
    Strassburg, S.
    Welsner, M.
    Sutharsan, S.
    Taube, C.
    Reuter, S.
    PNEUMOLOGIE, 2023, 77 : S7 - S7
  • [42] Limited effectiveness of elexacaftor-tezacaftor-ivacaftor on lung hyperinflation in adults with cystic fibrosis
    Dhote, Theo
    Martin, Clemence
    Regard, Lucile
    Kanaan, Reem
    Carlier, Nicolas
    Honore, Isabelle
    Fesenbeckh, Johanna
    Burnet, Esperie
    Fajac, Isabelle
    Aubourg, Frederique
    Perez, Thierry
    Da Silva, Jennifer
    Burgel, Pierre-Regis
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [43] Muscle strength and exercise capacity in CF adults following initiation of elexacaftor/tezacaftor/ivacaftor
    Hall, Kathleen
    Cobb, Robyn
    Bingham, Jennifer
    Hartel, Gunter
    Reid, David
    RESPIROLOGY, 2024, 29 : 32 - 32
  • [44] Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapy
    Gramegna, Andrea
    Ruscica, Massimiliano
    Leonardi, Gloria
    Macchi, Chiara
    Fichtner, Isabella
    Putti, Gianmarco
    Schianca, Margherita Carnevale
    Terranova, Leonardo
    Alicandro, Gianfranco
    Blasi, Francesco
    JOURNAL OF CYSTIC FIBROSIS, 2025, 24 (01) : 53 - 56
  • [45] Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis
    Gramegna, Andrea
    Cimino, Giuseppe
    Cipolli, Marco
    Gandini, Giovanna
    Calderazzo, Maria Adelaide
    Profiti, Angelica
    Piedepalumbo, Federica
    Blasi, Francesco
    RESPIRATORY RESEARCH, 2025, 26 (01)
  • [46] Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist
    Tunney, Michael M.
    Wark, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (02)
  • [47] Elexacaftor-tezacaftor-ivacaftor increases airway nitric oxide in children with cystic fibrosis
    Martin, Isaac
    McDonald, Nancy
    Wilson, David
    Ratjen, Felix
    Grasemann, Hartmut
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 109 - 111
  • [48] Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
    Kam, Charissa W.
    Mckinzie, Cameron J.
    Omecene, Nicole E.
    Peters, Stacy
    Pettit, Rebecca S.
    Poisson, Margaret O.
    Witte, Jennifer
    PEDIATRIC PULMONOLOGY, 2025, 60 (01)
  • [49] Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy
    Piehler, Linus
    Thalemann, Ralf
    Lehmann, Christine
    Stahl, Mirjam
    Mall, Marcus A.
    Graeber, Simon Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (03) : 365 - 367
  • [50] Impact of elexacaftor/tezacaftor/ ivacaftor on fat soluble vitamin levels in children with cystic fibrosis
    Ly, Selina
    Robinson, Paul
    Douglas, Tonia
    Mitchell, Penny
    RESPIROLOGY, 2024, 29 : 43 - 43
12345